CTLT Catalent Inc

  1. Stocks
  2. Healthcare
  3. NYSE: CTLT

Price (delayed)

$65.975

Market cap

$11.88B

P/E Ratio

29.06

Dividend/share

N/A

EPS

$2.27

Enterprise value

$16.29B

Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It ...

Highlights
The stock's price to earnings (P/E) is 41% less than its 5-year quarterly average of 49.9 and 8% less than its last 4 quarters average of 32.0
CTLT's equity is up by 10% year-on-year and by 4.5% since the previous quarter
Catalent's quick ratio has decreased by 47% YoY and by 35% from the previous quarter
The net income has contracted by 32% YoY and by 3.8% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Peers: SUPN ICPT

Key stats

What are the main financial stats of CTLT
Market
Shares outstanding
180.09M
Market cap
$11.88B
Enterprise value
$16.29B
Valuations
Price to earnings (P/E)
29.06
Price to book (P/B)
2.42
Price to sales (P/S)
2.5
EV/EBIT
25.14
EV/EBITDA
15.53
EV/Sales
3.42
Earnings
Revenue
$4.76B
EBIT
$648M
EBITDA
$1.05B
Free cash flow
-$364M
Per share
EPS
$2.27
Free cash flow per share
-$2.02
Book value per share
$27.29
Revenue per share
$26.43
TBVPS
$38.27
Balance sheet
Total assets
$11.15B
Total liabilities
$6.24B
Debt
$4.85B
Equity
$4.91B
Working capital
$1.39B
Liquidity
Debt to equity
0.99
Current ratio
1.91
Quick ratio
0.91
Net debt/EBITDA
4.2
Margins
EBITDA margin
22.1%
Gross margin
32.7%
Net margin
8.6%
Operating margin
13.8%
Efficiency
Return on assets
3.9%
Return on equity
8.6%
Return on invested capital
7.1%
Return on capital employed
6.7%
Return on sales
13.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CTLT stock price

How has the Catalent stock price performed over time
Intraday
-1.21%
1 week
-5.53%
1 month
-2.49%
1 year
-38.85%
YTD
46.58%
QTD
46.58%

Financial performance

How have Catalent's revenue and profit performed over time
Revenue
$4.76B
Gross profit
$1.56B
Operating income
$655M
Net income
$410M
Gross margin
32.7%
Net margin
8.6%
The net margin has contracted by 36% YoY and by 2.3% from the previous quarter
The net income has contracted by 32% YoY and by 3.8% from the previous quarter
Catalent's operating margin has decreased by 16% YoY and by 2.1% from the previous quarter
Catalent's operating income has decreased by 11% YoY and by 3.4% QoQ

Growth

What is Catalent's growth rate over time

Valuation

What is Catalent stock price valuation
P/E
29.06
P/B
2.42
P/S
2.5
EV/EBIT
25.14
EV/EBITDA
15.53
EV/Sales
3.42
The stock's price to earnings (P/E) is 41% less than its 5-year quarterly average of 49.9 and 8% less than its last 4 quarters average of 32.0
The company's EPS fell by 31% YoY and by 3.4% QoQ
The price to book (P/B) is 42% lower than the 5-year quarterly average of 4.2 and 23% lower than the last 4 quarters average of 3.2
CTLT's equity is up by 10% year-on-year and by 4.5% since the previous quarter
CTLT's price to sales (P/S) is 26% lower than its 5-year quarterly average of 3.4 and 21% lower than its last 4 quarters average of 3.2
The revenue has increased by 6% year-on-year

Efficiency

How efficient is Catalent business performance
Catalent's return on equity has decreased by 39% YoY and by 4.4% QoQ
CTLT's return on invested capital is down by 39% year-on-year
The company's return on assets fell by 34% YoY and by 4.9% QoQ
The company's return on sales fell by 30% YoY but it rose by 3.8% QoQ

Dividends

What is CTLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CTLT.

Financial health

How did Catalent financials performed over time
Catalent's total assets is 79% more than its total liabilities
Catalent's quick ratio has decreased by 47% YoY and by 35% from the previous quarter
The current ratio has declined by 33% since the previous quarter and by 33% year-on-year
The debt has grown by 15% from the previous quarter and by 15% YoY
The company's debt to equity rose by 11% QoQ and by 5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.